Learn More
Medchemexpress LLC ABT-737-d8 | 1217686-68-4 | 99.1% | C42H37D8ClN6O5S2 | 100 UG

Supplier: Medchemexpress LLC HY50907S100UG
ABT-737-d8 is the deuterium labeled ABT-737, a BH3 mimetic and a potent inhibitor of Bcl-2, Bcl-xL, and Bcl-w. It induces the disruption of the BCL-2/BAX complex and BAK-dependent, BIM-independent activation of the intrinsic apoptotic pathway, and also induces autophagy.
- Can be used as a tracer
- Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
- Has potential for acute myeloid leukemia (AML) research
- Stable heavy isotopes are incorporated into drug molecules for quantitation during drug development
- Deuteration can affect the pharmacokinetic and metabolic profiles of drugs
- For research use only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.